NCT01127295 2026-04-14
PHACS
Institut Claudius Regaud
Phase 4 Completed
Clinical Trials
17 trialsNCT01553903 2026-04-14
OXYTAM
Institut Claudius Regaud
Phase 4 Completed
NCT01612871 2026-04-14
MIRHO
Institut Claudius Regaud
Phase 4 Completed
NCT02661932 2025-01-31
Brovale
Erasme University Hospital
Phase 4 Completed
NCT03355157 2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4 Completed
NCT01035099 2022-12-13
RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF
Weill Medical College of Cornell University
Phase 4 Completed
NCT03948568 2022-09-30
REaCT-RETT
Ottawa Hospital Research Institute
Phase 4 Completed
NCT02679755 2022-07-27
Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer
Pfizer
Phase 4 Completed
NCT01999569 2022-04-22
The Role of Estrogen in Luteinizing Hormone Surge and Ovulation
Wake Forest University Health Sciences
Phase 4 Completed
NCT04069117 2022-04-06
Follicular Synchronization in PCOS Patients Undergoing ICSI
Mansoura University Hospital
Phase 4 Completed
NCT00688909 2021-06-09
REAL
Novartis
Phase 4 Completed
NCT02470741 2019-11-15
PLUM
University of California, San Francisco
Phase 4 Completed
NCT02802865 2019-09-27
Combined Letrozole and Clomid in Women With Infertility and PCOS
University of Iowa
Phase 4 Completed
NCT00237133 2017-02-24
PREDICT
Novartis
Phase 4 Completed
NCT00478504 2016-10-28
Letrozole Versus Clomifene Citrate for Ovulation Induction
University of Nottingham
Phase 4 Completed
NCT00014638 2013-02-21
Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
Novartis
Phase 4 Completed
NCT00237224 2009-11-19
Open Label Study of Postmenopausal Women With ER and /or PgR Positive Breast Cancer Treated With Letrozole
Novartis
Phase 4 Completed